Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookies. More details and information can be found in our Data Privacy Statement – please refer to this to adjust your settings for website analytics tracking (e.g. enable/disable). By closing this window you agree to our standard Terms of Use.

I'm ok with this


Updates & Features

Diagnostic Challenges of Small Fibre Neuropathy

February 2019

What current research is being conducted to overcome the diagnostic challenges of small fibre neuropathy?

Prof. Páll Karlsson, Aarhus University Hospital

Small fibre neuropathy (SFN) has until recently been a neglected subgroup among patients with neuropathy. SFN has a major impact on quality of life because of the underlying disease and the symptoms. SFN constitutes a heterogeneous group of neuropathies in which there is a selective or predominant damage or dysfunction of the thinly myelinated Aδ-fibres and/or unmyelinated C-fibres. Clinically, the patient usually presents with positive and negative symptoms due to small fibre dysfunction and in some cases cardiovascular, gastrointestinal and urogenital dysfunction due to affection of small fibres innervating these organs.


Share this with:

These are external links and will open in a new window